MSN is the third Indian firm to settle with Astellas Pharma over Myrbetriq after Lupin and Zydus Lifesciences. Astellas had filed patent infringement cases against the three Indian players ...
Intravesical bacillus Calmette-Guérin (BCG) remains the cornerstone of treatment for high-risk non–muscle-invasive bladder cancer (NMIBC). Despite decades ...
India, April 27 -- Waking up in the middle of the night to urinate might seem harmless-but it could be your body's early warning sign.
Legit.ng on MSN
How traders allegedly dilute palm oil with harmful substances to boost profits in Southeast markets, expert reacts
Traders in Onitsha have responded to claims of palm oil adulteration as experts raise concerns over health risks in the ...
The sudden, urgent need to pee when you get home—called "latchkey incontinence"—is caused by a combination of brain functions ...
The Centre for Research in Robotics and Underwater Technologies (CIRTESU) at the Universitat Jaume I in Castelló has ...
Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decreased by 44% and became increasingly ...
BD200 demonstrated superior uptake and cellular cytotoxicity when compared to approved drugs targeting either Trop-2 or ...
Gear Break for April 17 is focused on affordable tech n’ spec for allroad and gravel; riding and racing doesn’t have to break ...
Bladder cancer remains a major public health burden in the United States. The American Cancer Society estimates 84,870 new cases of bladder cancer and 17,420 deaths annually in the United States, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results